Foresight Diagnostics is a molecular diagnostics company specializing in noninvasive cancer detection technologies aimed at improving patient outcomes globally. The company develops a range of cell-free DNA-based liquid biopsy tests, leveraging proprietary methods initially developed at Stanford University. This technology facilitates earlier detection of smaller tumors, promoting personalized and effective treatment strategies. With a strong foundation in molecular biology, bioinformatics, and Next Generation Sequencing (NGS), Foresight Diagnostics fosters a dynamic and fast-paced work environment that encourages high-impact contributions and rapid professional growth. Headquartered in Boulder, Colorado, the company offers employees opportunities to engage with groundbreaking advancements in cancer detection and to play a vital role in transforming the landscape of patient care.